The MedCity Moves Podcast has returned with another episode. We discuss some of the executive appointments occurring in the healthcare world over the past month — including new leaders at Cleveland Clinic, UnitedHealth Group and Signify Health. We also talk about layoffs affecting the industry — including the recent rounds of job cuts at Optum and CVS.
For this month’s guest interview, we are joined by Andrew Trister, who just became Verily‘s chief scientific officer. In this role, he will lead the company’s population health initiatives and help advance its precision health strategies.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
To hear the full episode and learn which health technology Trister is most excited about, click here:
